TimesSquare Capital Management’s MoonLake Immunotherapeutics MLTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-203,737
| Closed | -$8.96M | – | 162 |
|
|
2024
Q2 | $8.96M | Sell |
203,737
-5,750
| -3% | -$253K | 0.14% | 140 |
|
|
2024
Q1 | $10.5M | Sell |
209,487
-279,318
| -57% | -$14M | 0.15% | 142 |
|
|
2023
Q4 | $29.5M | Buy |
488,805
+77,590
| +19% | +$4.69M | 0.43% | 93 |
|
|
2023
Q3 | $23.4M | Buy |
411,215
+381,215
| +1,271% | +$21.7M | 0.36% | 109 |
|
|
2023
Q2 | $1.53M | Buy |
+30,000
| New | +$1.53M | 0.02% | 165 |
|